Daniel M. Berney

33.4k total citations · 7 hit papers
250 papers, 10.2k citations indexed

About

Daniel M. Berney is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Daniel M. Berney has authored 250 papers receiving a total of 10.2k indexed citations (citations by other indexed papers that have themselves been cited), including 140 papers in Pulmonary and Respiratory Medicine, 122 papers in Surgery and 70 papers in Molecular Biology. Recurrent topics in Daniel M. Berney's work include Prostate Cancer Treatment and Research (82 papers), Testicular diseases and treatments (66 papers) and Prostate Cancer Diagnosis and Treatment (60 papers). Daniel M. Berney is often cited by papers focused on Prostate Cancer Treatment and Research (82 papers), Testicular diseases and treatments (66 papers) and Prostate Cancer Diagnosis and Treatment (60 papers). Daniel M. Berney collaborates with scholars based in United Kingdom, United States and Canada. Daniel M. Berney's co-authors include Jack Cuzick, Peter T. Scardino, Henrik Møller, Gabrielle Fisher, Christopher S. Foster, John R. Srigley, Lars Egevad, Rodolfo Montironi, Satish K. Tickoo and Leendert H. J. Looijenga and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Daniel M. Berney

244 papers receiving 10.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

WHO Classification of of Tumours of the Urinary System and Male Genital Organs

2016 587 citations Daniel M. Berney et al. profile →
Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study

2011 548 citations Jack Cuzick, Gabrielle Fisher et al. profile →
The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours

2022 399 citations Holger Moch, Mahul B. Amin et al. profile →
Testicular cancer

2018 302 citations Daniel M. Berney, Gedske Daugaard et al. profile →
The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs—Part B: Prostate and Urinary Tract Tumors

2022 140 citations George J. Netto, Mahul B. Amin et al. profile →
Testicular seminoma and non-seminoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up

2022 99 citations Daniel M. Berney, Gedske Daugaard et al. profile →
European Association of Urology Guidelines on Testicular Cancer: 2023 Update

2023 99 citations Daniel M. Berney et al. profile →

Peers

Countries citing papers authored by Daniel M. Berney

Since Specialization

Citations

This map shows the geographic impact of Daniel M. Berney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel M. Berney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel M. Berney more than expected).

Fields of papers citing papers by Daniel M. Berney

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel M. Berney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel M. Berney. The network helps show where Daniel M. Berney may publish in the future.

Co-authorship network of co-authors of Daniel M. Berney

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel M. Berney. A scholar is included among the top collaborators of Daniel M. Berney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel M. Berney. Daniel M. Berney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Second edition ICCR dataset for testicular germ cell tumours: a reporting guide for histopathological diagnosis of orchiectomy specimens 2025 ·Histopathology ·Felix Bremmer, Fleur Webster, Gedske Daugaard, Robert J. Hamilton, Muhammad T. Idrees, Chia‐Sui Kao, Kosuke Miyai, Maria Rosaria Raspollini, John R. Srigley, Satish K. Tickoo, Aslı Yilmaz, Thomas Wagner, Daniel M. Berney	1
2	Analysis of MicroRNA-371-373 supports that a subset of spermatocytic tumors demonstrates biologic features similar to those of GCNIS-derived germ cell tumors 2024 ·Human Pathology ·João Lobo, (unknown), Cármen Jerónimo, Rui Henrique, (unknown), Kristine M. Cornejo, Daniel M. Berney, Thomas M. Ulbright, Sounak Gupta, (unknown)	5
3	WHOClassification of Tumours fifth edition: evolving issues in the classification, diagnosis, and prognostication of prostate cancer 2022 ·Histopathology ·James G. Kench, Mahul B. Amin, Daniel M. Berney, Éva Compérat, Ian A. Cree, Anthony J. Gill, Arndt Hartmann, Santosh Menon, Holger Moch, George J. Netto, Maria Rosaria Raspollini, Mark A. Rubin, Puay Hoon Tan, Toyonori Tsuzuki, (unknown), Theodorus van der Kwast, Ming Zhou, John R. Srigley	26
4	WHO 2022 classification of penile and scrotal cancers: updates and evolution 2022 ·Histopathology ·Santosh Menon, Holger Moch, Daniel M. Berney, (unknown), (unknown), Toyonori Tsuzuki, Éva Compérat, Arndt Hartmann, George J. Netto, Mark A. Rubin, (unknown), Samra Turajlic, PH Tan, (unknown), (unknown), Mahul B. Amin	21
5	What's new in WHO fifth edition – urinary tract 2022 ·Histopathology ·Éva Compérat, Mahul B. Amin, Daniel M. Berney, Ian A. Cree, Santosh Menon, Holger Moch, George J. Netto, (unknown), (unknown), Mark A. Rubin, John R. Srigley, Puay Hoon Tan, Satish K. Tickoo, Samra Turajlic, Toyonori Tsuzuki	16
6	WHO 2022 landscape of papillary and chromophobe renal cell carcinoma 2022 ·Histopathology ·João Lobo, Riuko Ohashi, Mahul B. Amin, Daniel M. Berney, Éva Compérat, Ian A. Cree, Anthony J. Gill, Arndt Hartmann, Santosh Menon, George J. Netto, Maria Rosaria Raspollini, Mark A. Rubin, Puay Hoon Tan, Satish K. Tickoo, Toyonori Tsuzuki, Samra Turajlic, Ming Zhou, John R. Srigley, Holger Moch	61
7	The Transcriptomic Landscape of Prostate Cancer Development and Progression: An Integrative Analysis 2021 ·Cancers ·Jacek Marzec, Helen Ross‐Adams, S Pirro, Jun Wang, Yanan Zhu, Xueying Mao, Emanuela Gadaleta, Amar Ahmad, Bernard V. North, Solène‐Florence Kammerer‐Jacquet, Elzbieta Stankiewicz, Sakunthala C. Kudahetti, Luis Beltrán, Guoping Ren, Daniel M. Berney, Yong‐Jie Lu, Claude Chelala	7
8	Management of Late Relapses After Chemotherapy in Testicular Cancer: Optimal Outcomes with Dose-intense Salvage Chemotherapy and Surgery 2020 ·European Urology Focus ·Constantine Alifrangis, Olivia Lucas, Sarah Benafif, Wendy Ansell, Michelle Greenwood, (unknown), Peter Wilson, Benjamin Thomas, Sarah Rudman, Danish Mazhar, Daniel M. Berney, Jonathan Shamash	7
9	Handling and reporting of pelvic lymphadenectomy specimens in prostate and bladder cancer: a web‐based survey by the European Network of Uropathology 2019 ·Histopathology ·Susan Prendeville, Daniel M. Berney, Lukas Bubendorf, Éva Compérat, Lars Egevad, Ondřej Hes, Glen Kristiansen, Jon Oxley, Geert J.L.H. van Leenders, Murali Varma, Theodorus van der Kwast	5
10	Fumarate hydratase deficient renal cell carcinoma and fumarate hydratase deficient-like renal cell carcinoma: Morphologic comparative study of 23 genetically tested cases. 2019 ·PubMed ·Kristýna Pivovarčíková, Petr Martínek, Kiril Trpkov, Reza Alaghehbandan, Cristina Magi‐Galluzzi, Enric Condom, Daniel M. Berney, Saul Suster, Anthony J. Gill, Boris Rychlý, Květoslava Michalová, (unknown), Milan Hora, Michal Michal, Ondřej Hes	3
11	The Novel Association of Circulating Tumor Cells and Circulating Megakaryocytes with Prostate Cancer Prognosis 2017 ·Clinical Cancer Research ·Lei Xu, Xueying Mao, Tianyu Guo, Pui Ying Chan, Greg Shaw, John Hines, Elzbieta Stankiewicz, Yuqin Wang, R.T.D. Oliver, Amar Ahmad, Daniel M. Berney, Jonathan Shamash, Yong‐Jie Lu	54
12	Defining a New Prognostic Index for Stage I Nonseminomatous Germ Cell Tumors Using CXCL12 Expression and Proportion of Embryonal Carcinoma 2015 ·Clinical Cancer Research ·Duncan C. Gilbert, Reem Al‐Saadi, Khin Thway, Ian Chandler, Daniel M. Berney, Rhian Gabe, Sally Stenning, Joan Sweet, Robert Huddart, Janet Shipley	18
13	Sunitinib Treatment Exacerbates Intratumoral Heterogeneity in Metastatic Renal Cancer 2015 ·Clinical Cancer Research ·Grant D. Stewart, Fiach C. O’Mahony, Alexander Laird, Lél Eöry, (unknown), Alan Mackay, Jyoti Nanda, Marie O’Donnell, Peter Mullen, S. Alan McNeill, Antony C. P. Riddick, Daniel M. Berney, Axel Bex, Michael Aitchison, Ian M. Overton, David J. Harrison, Thomas Powles	29
14	Validation of an RNA cell cycle progression score for predicting death from prostate cancer in a conservatively managed needle biopsy cohort 2015 ·British Journal of Cancer ·(unknown), Jack Cuzick, Steven Stone, Gabrielle Fisher, Zi Yang, Bernard V. North, Daniel M. Berney, Luis Beltrán, David Greenberg, Henrik Møller, (unknown), Alexander Gutin, Jerry S. Lanchbury, M K Brawer, Peter T. Scardino	109
15	Androgen-Induced TMPRSS2:ERG Fusion in Nonmalignant Prostate Epithelial Cells 2010 ·Cancer Research ·(unknown), Lara K. Boyd, Xueying Mao, Elzbieta Stankiewicz, Sakunthala C. Kudahetti, R.T.D. Oliver, Daniel M. Berney, Yong‐Jie Lu	78
16	Distinct Genomic Alterations in Prostate Cancers in Chinese and Western Populations Suggest Alternative Pathways of Prostate Carcinogenesis 2010 ·Cancer Research ·Xueying Mao, Yongwei Yu, Lara K. Boyd, Guoping Ren, Dongmei Lin, Tracy Chaplin, Sakunthala C. Kudahetti, Elzbieta Stankiewicz, Liyan Xue, Luis Beltrán, Manu Gupta, R.T.D. Oliver, Nicholas R. Lemoine, Daniel M. Berney, Bryan D. Young, Yong‐Jie Lu	126
17	SOX9 Elevation in the Prostate Promotes Proliferation and Cooperates with PTEN Loss to Drive Tumor Formation 2010 ·Cancer Research ·Martin K. Thomsen, Laurence Ambroisine, Sarah Wynn, Kathryn S.E. Cheah, Christopher S. Foster, Gabrielle Fisher, Daniel M. Berney, Henrik Møller, Victor E. Reuter, Peter T. Scardino, Jack Cuzick, Narasimhan Ragavan, Paras B. Singh, Francis L. Martin, Christopher M. Butler, Colin S. Cooper, Amanda Swain, (unknown)	114
18	Fibroblast growth factor 2 regulates endothelial cell sensitivity to sunitinib 2010 ·Oncogene ·Jonathan Welti, Morgane Gourlaouen, Thomas Powles, Sakunthala C. Kudahetti, Paul A. Wilson, Daniel M. Berney, Andrew R. Reynolds	106
19	Nonclassic Lipoid Congenital Adrenal Hyperplasia Masquerading as Familial Glucocorticoid Deficiency 2009 ·The Journal of Clinical Endocrinology & Metabolism ·Louise Metherell, Danielle Naville, G Halaby, Martine Bégeot, Angela Huebner, Gudrun Nürnberg, Peter Nürnberg, Jane Green, Jeremy Tomlinson, Nils Krone, Lin Lin, Michaël Racine, Daniel M. Berney, John C. Achermann, Wiebke Arlt, Adrian Clark	112
20	Ki-67 is an independent predictor of outcome in conservatively treated clinically localised prostate cancer 2008 ·Modern Pathology ·Daniel M. Berney, Anuradha Gopalan, Sakunthala C. Kudahetti, Laurence Ambroisine, Gabrielle Fisher, Michael W. Kattan, Henrik Møller, Corey C. Foster, Vincent Reuter, J. Cuzick, Peter L. Scardino, Carlton R. Cooper, William L. Gerald	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact